Robert Malasek - 10 Dec 2020 Form 4 Insider Report for AXIM BIOTECHNOLOGIES, INC. (AXIM)

Role
Chief Financial Officer
Signature
/s/ Robert Malasek
Issuer symbol
AXIM
Transactions as of
10 Dec 2020
Net transactions value
$0
Form type
4
Filing time
23 Sep 2022, 16:31:32 UTC
Next filing
23 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXIM Option Award $0 +300,000 $0.000000 300,000 10 Dec 2020 Common Stock 300,000 $0.4200 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.